| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 3.65% | 16.24% | -67.95% | 21/68 | 2.31% | 羚锐制药 | 6.99% | 行业排名> |
| 2025-12-31 | 11.39% | 255.81% | 21.95% | 14/68 | 2.77% | 羚锐制药 | 22.39% | 行业排名> |
| 2025-09-30 | 9.34% | 94.58% | 53.37% | 16/68 | 4.88% | 达仁堂 | 25.38% | 行业排名> |
| 2025-06-30 | 6.09% | 40.97% | 93.95% | 17/68 | 3.21% | 羚锐制药 | 13.67% | 行业排名> |
| 2025-03-31 | 3.14% | 19.85% | 142.95% | 20/68 | 2.25% | 天目药业 | 9.27% | 行业排名> |
| 2024-12-31 | -7.31% | -164.29% | -252.29% | 58/68 | 3.28% | 天目药业 | 22.26% | 行业排名> |
| 2024-09-30 | 4.8% | -68.77% | 11.11% | 34/68 | 5.46% | 羚锐制药 | 20.44% | 行业排名> |
| 2024-06-30 | 4.32% | -67.52% | 64.89% | 29/68 | 2.54% | 羚锐制药 | 13.25% | 行业排名> |
| 2024-03-31 | 2.62% | -74.88% | -76.96% | 32/68 | 1.97% | 片仔癀 | 7.03% | 行业排名> |
| 2023-12-31 | 11.37% | -51.05% | -26.02% | 17/68 | 2.03% | 片仔癀 | 23.1% | 行业排名> |
| 2023-09-30 | 15.37% | 4.42% | 15.56% | 7/68 | 7.62% | 太极集团 | 22.08% | 行业排名> |
| 2023-06-30 | 13.3% | 21.46% | 27.52% | 2/68 | 5.2% | 太极集团 | 17.13% | 行业排名> |
| 2023-03-31 | 10.43% | 100.58% | -55.1% | 1/68 | 3.31% | 以岭药业 | 10.43% | 行业排名> |
| 2022-12-31 | 23.23% | 65.22% | 57.81% | 2/68 | 6.79% | *ST吉药 | 72.63% | 行业排名> |
| 2022-09-30 | 14.72% | 9.85% | 34.43% | 6/68 | 5.19% | 片仔癀 | 23.54% | 行业排名> |
| 2022-06-30 | 10.95% | 11.39% | 110.58% | 2/68 | 3.33% | 片仔癀 | 19.69% | 行业排名> |
| 2022-03-31 | 5.2% | -27.27% | -63.02% | 9/68 | 2.18% | 片仔癀 | 12.75% | 行业排名> |
| 2021-12-31 | 14.06% | 1.59% | 4.93% | 10/68 | 4.51% | 片仔癀 | 6.88% | 行业排名> |
| 2021-09-30 | 13.4% | 10.02% | 36.32% | 7/68 | 7.47% | 片仔癀 | 27.39% | 行业排名> |
| 2021-06-30 | 9.83% | 17.44% | 37.48% | 5/68 | 4.6% | 片仔癀 | 23.14% | 行业排名> |
| 2021-03-31 | 7.15% | 33.4% | -48.34% | 1/68 | 2.63% | 片仔癀 | 13.23% | 行业排名> |
| 2020-12-31 | 13.84% | 93.03% | 13.63% | 8/68 | 0.07% | 长药退 | 7.37% | 行业排名> |
| 2020-09-30 | 12.18% | 65.49% | 45.52% | 8/68 | 6.89% | 以岭药业 | 7.15% | 行业排名> |
| 2020-06-30 | 8.37% | 51.63% | 56.16% | 5/68 | 3.83% | 沃华医药 | 22.84% | 行业排名> |
| 2020-03-31 | 5.36% | 42.93% | -25.24% | 4/68 | 2.18% | 沃华医药 | 19.47% | 行业排名> |
| 2019-12-31 | 7.17% | -7.24% | -2.58% | 37/68 | 6.88% | 沃华医药 | 12.7% | 行业排名> |
| 2019-09-30 | 7.36% | -0.27% | 33.33% | 35/68 | 7.39% | 济川药业 | 7.33% | 行业排名> |
| 2019-06-30 | 5.52% | -4.17% | 47.2% | 24/68 | 4.75% | 济川药业 | 27.43% | 行业排名> |
| 2019-03-31 | 3.75% | -11.97% | -51.49% | 17/68 | 2.94% | 济川药业 | 23.05% | 行业排名> |
| 2018-12-31 | 7.73% | -0.39% | 4.74% | 40/68 | 7.89% | 济川药业 | 15.79% | 行业排名> |
| 2018-09-30 | 7.38% | 10.15% | 28.13% | 33/68 | 8.02% | 华润三九 | 10.23% | 行业排名> |
| 2018-06-30 | 5.76% | 10.98% | 35.21% | 27/68 | 5.05% | 济川药业 | 32.79% | 行业排名> |
| 2018-03-31 | 4.26% | 22.41% | -45.1% | 11/68 | 2.78% | 济川药业 | 27.55% | 行业排名> |
| 2017-12-31 | 7.76% | -26.58% | 15.82% | 43/68 | 9.95% | 济川药业 | 17.62% | 行业排名> |
| 2017-09-30 | 6.7% | -20.9% | 29.09% | 41/68 | 8.4% | 济川药业 | 10.07% | 行业排名> |
| 2017-06-30 | 5.19% | -17.62% | 49.14% | 34/68 | 5.23% | ST葫芦娃 | 46.01% | 行业排名> |
| 2017-03-31 | 3.48% | -6.2% | -67.08% | 21/68 | 2.66% | 济川药业 | 24.2% | 行业排名> |
| 2016-12-31 | 10.57% | 13.05% | 24.79% | 32/68 | 10.19% | *ST大药 | 15.31% | 行业排名> |
| 2016-09-30 | 8.47% | 20.83% | 34.44% | 31/68 | 9.47% | 济川药业 | 14.64% | 行业排名> |
| 2016-06-30 | 6.3% | 34.62% | 69.81% | 27/68 | 5.15% | 济川药业 | 7.64% | 行业排名> |
| 2016-03-31 | 3.71% | 38.43% | -60.32% | 20/68 | 4.17% | 维康药业 | 38.23% | 行业排名> |

微信公众号
证券之星APP


